Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Association Between Diazinon Exposure and Dyslipidemia Occurrence: A Systematic and Meta-Analysis Study Publisher Pubmed



Aramjoo H1 ; Farkhondeh T2, 3 ; Aschner M4 ; Naseri K2, 3 ; Mehrpour O5, 6 ; Sadighara P7 ; Roshanravan B8 ; Samarghandian S9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, BSc Student in Medical Laboratory Science, Birjand University of Medical Sciences, Birjand, Iran
  2. 2. Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences (BUMS), Birjand, Iran
  3. 3. Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran
  4. 4. Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer 209 1300 Morris Park Avenue, Bronx, NY, United States
  5. 5. Arizona Poison & Drug Information Center, the University of Arizona, College of Pharmacy and University of Arizona, Tucson, AZ, United States
  6. 6. Scientific Unlimited Horizon, Tucson, AZ, United States
  7. 7. Department of Environmental Health Engineering, Food Safety Division, School of Public Health and Center for Environmental Research, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran
  9. 9. Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran

Source: Environmental Science and Pollution Research Published:2021


Abstract

The effects of diazinon (DZN), an organophosphate pesticide, on lipid profiles have been extensively reported. However, controversy on this issue persists. Here, we performed a systematic and meta-analysis study to investigate the association between DZN exposure and dyslipidemia in rodents and fish species. This systematic review was prepared according to the PRISMA guidelines. Main databases, including Google Scholar, Scopus, PubMed, Ovid MEDLINE, and Web of Science, were systematically searched through March 4, 2020. The risk of bias was evaluated with the SYRCLE’s RoB tool. Once all articles were assessed for scientific quality, a random-effects model was applied to perform a pooled analysis. I2 and Q test were used to assess the heterogeneity between articles, and Forest plots, indicating point and pooled estimates, were drawn. Twenty-eight articles were included; between them, 13 publications were selected for meta-analysis. Random-effects meta-analysis showed low heterogeneity between the articles. A pooled analysis indicated that DZN significantly increased total cholesterol levels (95% CI: 0.86–3.79; Z = 3.10; p = 0.002), triglyceride (95% CI: 0.38–3.22; Z = 2.48; p = 0.09), low-density lipoprotein cholesterol (95% CI: 0.25–2.85; Z = 2.34; p = 0.7) in the DZN vs. control groups. In addition, DZN significantly decreased high-density lipoprotein cholesterol (95% CI: − 2.92, − 0.42; Z = 2.62; p = 0.07) in the DZN vs. control groups. No publication bias was observed. Our findings suggest that DZN induces dyslipidemia in rodents and fish species in a dose-dependent manner. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.